<!-- html table generated in R 3.3.1 by xtable 1.8-2 package -->
<!-- Thu Mar 29 18:06:12 2018 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0009952 </td> <td align="right"> 1.9e-13 </td> <td align="right"> 5.60 </td> <td align="right"> 7.21 </td> <td align="right">  33 </td> <td align="right"> 187 </td> <td> anterior/posterior pattern specification </td> <td> BASP1, EMX2, EN1, FOXC2, HHEX, HOXA5, HOXA6, HOXA7, HOXA9, HOXA10, HOXB5, HOXB8, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC11, HOXC13, HOXD8, HOXD9, HOXD10, MYF5, MYF6, LEF1, PCSK5, SHH, TBX1, TBX3, WNT2, AXIN2, HES7, TBX18 </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0007389 </td> <td align="right"> 6.7e-10 </td> <td align="right"> 3.18 </td> <td align="right"> 15.74 </td> <td align="right">  44 </td> <td align="right"> 408 </td> <td> pattern specification process </td> <td> BASP1, CCDC151, FOXN4, EMX2, EN1, EVX1, FOXC2, GLI1, HHEX, HOXA5, HOXA6, HOXA7, HOXA9, HOXA10, HOXB5, HOXB8, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC11, HOXC13, HOXD8, HOXD9, HOXD10, MYF5, MYF6, IFT52, LEF1, PCSK5, HSPB11, SHH, SIX1, TBX1, TBX3, NKX2-1, WNT2, PAX8, AXIN2, HES7, ACVR1, TBX18, LHX2 </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:0048704 </td> <td align="right"> 4.2e-08 </td> <td align="right"> 6.03 </td> <td align="right"> 3.43 </td> <td align="right">  17 </td> <td align="right">  89 </td> <td> embryonic skeletal system morphogenesis </td> <td> OSR2, FOXC2, MTHFD1L, HOXA1, HOXA5, HOXA6, HOXA7, HOXB5, HOXB8, HOXC9, HOXC11, HOXD9, HOXD10, MYF5, SIX1, TBX1, TBX15 </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:0042693 </td> <td align="right"> 1e-06 </td> <td align="right"> 19.61 </td> <td align="right"> 0.62 </td> <td align="right">   7 </td> <td align="right">  16 </td> <td> muscle cell fate commitment </td> <td> MYF5, MYF6, MYOD1, MYOG, TBX1, TBX3, ACVR1 </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:0009792 </td> <td align="right"> 1e-05 </td> <td align="right"> 2.21 </td> <td align="right"> 20.64 </td> <td align="right">  42 </td> <td align="right"> 535 </td> <td> embryo development ending in birth or egg hatching </td> <td> OSR2, CYP1A1, FLCN, EN1, EVX1, EXT1, FOXC2, FZD2, MTHFD1L, GATA1, HHEX, HOXA1, HOXA5, HOXA6, HOXA7, HOXA9, HOXB5, HOXB8, HOXC5, HOXC6, HOXC9, HOXC11, HOXD9, HOXD10, INPP5B, MYF5, MYF6, NMT1, IFT52, LEF1, PCSK5, SHH, SIX1, TBX1, TBX15, TBX3, WNT2, ZFAND5, AXIN2, HES7, ACVR1, LHX2 </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0060173 </td> <td align="right"> 1.7e-05 </td> <td align="right"> 3.37 </td> <td align="right"> 6.29 </td> <td align="right">  19 </td> <td align="right"> 163 </td> <td> limb development </td> <td> OSR2, EN1, FGF4, GJA5, HOXA9, HOXA10, HOXC10, HOXC11, HOXC13, HOXD9, HOXD10, EVX2, IFT52, LEF1, PCSK5, SALL1, SMOC1, SHH, TBX3 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0009954 </td> <td align="right"> 2.2e-05 </td> <td align="right"> 8.41 </td> <td align="right"> 1.23 </td> <td align="right">   8 </td> <td align="right">  32 </td> <td> proximal/distal pattern formation </td> <td> EN1, GLI1, HOXA9, HOXA10, HOXC10, HOXC11, HOXD9, HOXD10 </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0030878 </td> <td align="right"> 2.4e-05 </td> <td align="right"> 10.37 </td> <td align="right"> 0.93 </td> <td align="right">   7 </td> <td align="right">  24 </td> <td> thyroid gland development </td> <td> HHEX, HOXA5, SHH, SIX1, TBX1, NKX2-1, PAX8 </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0035107 </td> <td align="right"> 3.1e-05 </td> <td align="right"> 3.49 </td> <td align="right"> 5.44 </td> <td align="right">  17 </td> <td align="right"> 141 </td> <td> appendage morphogenesis </td> <td> OSR2, EN1, FGF4, GJA5, HOXA9, HOXA10, HOXC10, HOXC11, HOXD9, HOXD10, EVX2, IFT52, LEF1, PCSK5, SALL1, SHH, TBX3 </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0048568 </td> <td align="right"> 3.9e-05 </td> <td align="right"> 2.49 </td> <td align="right"> 12.19 </td> <td align="right">  28 </td> <td align="right"> 319 </td> <td> embryonic organ development </td> <td> OSR2, EN1, EPHB2, FZD2, MTHFD1L, GATA1, GLI1, HOXA1, HOXA5, HOXA6, HOXA7, HOXB5, HOXB8, HOXC9, HOXC11, HOXD9, HOXD10, ID2, MYF5, LEF1, PCSK5, SALL1, SIX1, FOXL2, TBX1, TBX15, WNT2, PAX8 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:0009887 </td> <td align="right"> 9e-05 </td> <td align="right"> 1.91 </td> <td align="right"> 26.41 </td> <td align="right">  47 </td> <td align="right"> 695 </td> <td> animal organ morphogenesis </td> <td> BASP1, OSR2, COL13A1, CRIP1, CTGF, DCN, EPHB2, ESR1, ETV4, FGF4, FOXL1, FOXO1, NPNT, MTHFD1L, GATA1, GLI1, HHEX, HOXA1, HOXA5, HOXA6, HOXA7, HOXB5, HOXB8, HOXC8, HOXC9, HOXC11, HOXC13, HOXD8, HOXD9, HOXD10, ID4, RHOA, MYF5, MYF6, LEF1, PAPPA2, ROM1, SALL1, SFTPB, FOXL2, TBX15, NKX2-1, VDR, ZFAND5, PAX8, KLK4, MAGI2 </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:0045907 </td> <td align="right"> 0.00014 </td> <td align="right"> 7.34 </td> <td align="right"> 1.20 </td> <td align="right">   7 </td> <td align="right">  31 </td> <td> positive regulation of vasoconstriction </td> <td> ADRA1B, ADRA2C, DBH, FGG, GJA5, HTR2A, TBXA2R </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0015721 </td> <td align="right"> 0.00038 </td> <td align="right"> 7.54 </td> <td align="right"> 1.00 </td> <td align="right">   6 </td> <td align="right">  26 </td> <td> bile acid and bile salt transport </td> <td> SLCO1B1, AKR1C1, FABP6, SLCO1B3, SLC10A3, ABCC3 </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:0048641 </td> <td align="right"> 0.00039 </td> <td align="right"> 5.17 </td> <td align="right"> 1.81 </td> <td align="right">   8 </td> <td align="right">  47 </td> <td> regulation of skeletal muscle tissue development </td> <td> TSC22D3, MYF5, MYF6, MYOD1, MYOG, SHH, SIX1, TBX1 </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0032502 </td> <td align="right"> 0.00043 </td> <td align="right"> 1.34 </td> <td align="right"> 204.60 </td> <td align="right"> 243 </td> <td align="right"> 5339 </td> <td> developmental process </td> <td> NR1H3, CPQ, BASP1, CAP1, CEBPE, MAB21L2, IGF2BP1, CFL2, GADD45G, INSL6, ADAMTS6, KRT71, CHRND, CCDC151, OSR2, WFIKKN1, CLC, GTSF1, FOXN4, ZPBP2, WTIP, COL13A1, ADAD1, ASZ1, CRIP1, CRP, CSNK2B, ADRA1B, DACT3, CTGF, TCF23, ADRA2C, CNTN4, CYP1A1, SAXO1, CYP17A1, DCN, AKR1C1, AKR1C2, FAM9B, DHODH, DIO3, DLX4, JAG1, TSC22D3, FLCN, EMX2, EN1, EPHB2, EPOR, EYA4, ESR1, ETV4, EVX1, EXT1, F2, KDM1B, FGF4, FGG, VEGFD, FOXL1, FOXC2, FOXO1, PRAME, CLEC5A, STAC3, FZD2, FAM21C, NPNT, FBXO7, MTHFD1L, PTPN23, GAS1, PTPN22, GATA1, BLOC1S1, GJA5, NOX1, ANKRD1, GLI1, GNG5, GNRH1, GNRH2, METRNL, IGSF10, ANXA4, HHEX, HMGB2, HMGB3, HOXA1, HOXA5, HOXA6, HOXA7, HOXA9, HOXA10, HOXB5, HOXB8, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC13, HOXD8, HOXD9, HOXD10, HSD11B1, HSD17B1, HTR2A, NANOS2, ID2, ID4, EVX2, LCE1D, LCE3C, IL12RB1, IDO1, INPP5B, RHOA, KRT35, MUSTN1, SPATA31D1, STMN1, FADS1, MATN3, ASGR2, MNAT1, NUDT1, MYF5, MYF6, SERPINC1, MYOD1, MYOG, NDP, NEB, NFE2, NMT1, NPPA, NRGN, NTF3, C8orf22, TRIM72, OMG, NOX4, REG3A, IFT52, LEF1, PCSK5, CLEC1B, SPTBN5, PRRX2, VCX2, HSPB11, ENPP2, PFKFB3, PHEX, GPR173, POLR2G, MOV10L1, ULK4, CRTAC1, PPP2R1B, MCOLN3, AP1AR, HES6, CARMIL1, PRKD1, RETN, ATP10A, PRX, MYOZ1, RBP2, REST, PAPPA2, ROM1, BDNF, SCN1B, CCL13, CCL17, DMRTB1, PRDM16, SMOC1, TNMD, SFRP4, RAD21L1, SFTPB, SFTPD, SHH, BMX, BOLL, FOXL2, SRD5A2, SSTR1, VAMP7, TAGLN, TBX1, TBCE, TBX15, TBXA2R, TBX3, BTG1, LEFTY2, THPO, TNNI1, TPH1, UCP3, SCGB1A1, VDR, VRK2, ZFAND5, LRP8, PAX8, KCNAB1, CATSPERB, HDAC11, SYNDIG1, TRIM45, HMGA2, HIST1H4I, AXIN2, MAD1L1, SPATA16, ANTXR1, SOAT2, CYSTM1, PROK1, HES7, SLC22A16, STON2, TMEFF1, AKR1C3, KRT36, CCIN, ACVR1, TBX18, KRT75, AURKB, PRDM6, LHX2, CD101, GNG8, KLK4, MAGI2 </td> </tr>
  <tr> <td> 16 </td> <td align="center"> GO:0048598 </td> <td align="right"> 0.00047 </td> <td align="right"> 1.94 </td> <td align="right"> 19.22 </td> <td align="right">  35 </td> <td align="right"> 503 </td> <td> embryonic morphogenesis </td> <td> MAB21L2, OSR2, FOXN4, EN1, EPHB2, EXT1, FGF4, GJA5, GLI1, HHEX, HOXA5, HOXA6, HOXA7, HOXA9, HOXA10, HOXB5, HOXB8, HOXC9, HOXC10, HOXC11, HOXD9, HOXD10, ID2, MYF5, IFT52, LEF1, SHH, FOXL2, TBX15, TBX3, WNT2, PAX8, HMGA2, ACVR1, LHX2 </td> </tr>
  <tr> <td> 17 </td> <td align="center"> GO:0007517 </td> <td align="right"> 0.00051 </td> <td align="right"> 2.17 </td> <td align="right"> 12.81 </td> <td align="right">  26 </td> <td align="right"> 332 </td> <td> muscle organ development </td> <td> BASP1, CHRND, TCF23, DCN, TSC22D3, FOXC2, STAC3, FZD2, ANKRD1, HOXD9, HOXD10, MYF5, MYF6, MYOD1, MYOG, NEB, TRIM72, LEF1, SHH, SIX1, FOXL2, TAGLN, TBX1, TNNI1, WNT2, KCNAB1 </td> </tr>
  <tr> <td> 18 </td> <td align="center"> GO:0045663 </td> <td align="right"> 0.00062 </td> <td align="right"> 8.97 </td> <td align="right"> 0.73 </td> <td align="right">   5 </td> <td align="right">  19 </td> <td> positive regulation of myoblast differentiation </td> <td> MYF5, MYF6, MYOD1, MYOG, BTG1 </td> </tr>
  <tr> <td> 19 </td> <td align="center"> GO:0048706 </td> <td align="right"> 0.00063 </td> <td align="right"> 6.73 </td> <td align="right"> 1.09 </td> <td align="right">   6 </td> <td align="right">  29 </td> <td> embryonic skeletal system development </td> <td> EXT1, HOXA9, HOXC5, HOXC6, PCSK5, SHH </td> </tr>
  <tr> <td> 20 </td> <td align="center"> GO:0042537 </td> <td align="right"> 0.0008 </td> <td align="right"> 8.37 </td> <td align="right"> 0.77 </td> <td align="right">   5 </td> <td align="right">  20 </td> <td> benzene-containing compound metabolic process </td> <td> IDO2, IDO1, AADAT, SRD5A2, TDO2 </td> </tr>
  <tr> <td> 21 </td> <td align="center"> GO:1902742 </td> <td align="right"> 0.00086 </td> <td align="right"> 6.28 </td> <td align="right"> 1.16 </td> <td align="right">   6 </td> <td align="right">  30 </td> <td> apoptotic process involved in development </td> <td> FGF4, FOXC2, LEF1, PPP2R1B, VDR, PAX8 </td> </tr>
  <tr> <td> 22 </td> <td align="center"> GO:0071347 </td> <td align="right"> 0.00098 </td> <td align="right"> 3.60 </td> <td align="right"> 3.09 </td> <td align="right">  10 </td> <td align="right">  80 </td> <td> cellular response to interleukin-1 </td> <td> CCL26, ANKRD1, OTUB1, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23, VRK2 </td> </tr>
  <tr> <td> 23 </td> <td align="center"> GO:0072359 </td> <td align="right"> 0.001 </td> <td align="right"> 1.64 </td> <td align="right"> 34.26 </td> <td align="right">  53 </td> <td align="right"> 888 </td> <td> circulatory system development </td> <td> BASP1, ADAMTS6, FOXN4, CRIP1, CTGF, DCN, JAG1, EPHB2, EPOR, VEGFD, FOXL1, FOXC2, FOXO1, FZD2, GATA1, GJA5, NOX1, ANKRD1, GNG5, HHEX, HOXA1, HOXA5, HOXA7, ID2, RHOA, MNAT1, NDP, NPPA, NOX4, IFT52, LEF1, PCSK5, HSPB11, ENPP2, PRKD1, REST, ROM1, SALL1, TNMD, SHH, SIX1, TBX1, TBXA2R, TBX3, BTG1, TNNI1, WNT2, ZFAND5, KCNAB1, AXIN2, ANTXR1, PROK1, ACVR1 </td> </tr>
  <tr> <td> 24 </td> <td align="center"> GO:0035115 </td> <td align="right"> 0.001 </td> <td align="right"> 6.03 </td> <td align="right"> 1.20 </td> <td align="right">   6 </td> <td align="right">  31 </td> <td> embryonic forelimb morphogenesis </td> <td> OSR2, EN1, HOXA9, HOXD9, SHH, TBX3 </td> </tr>
  <tr> <td> 25 </td> <td align="center"> GO:0001763 </td> <td align="right"> 0.0011 </td> <td align="right"> 2.51 </td> <td align="right"> 7.29 </td> <td align="right">  17 </td> <td align="right"> 189 </td> <td> morphogenesis of a branching structure </td> <td> COL13A1, ESR1, ETV4, FOXC2, NPNT, HHEX, HOXA5, LEF1, SALL1, SHH, SIX1, TBX3, NKX2-1, VDR, WNT2, PAX8, ACVR1 </td> </tr>
  <tr> <td> 26 </td> <td align="center"> GO:0030879 </td> <td align="right"> 0.0011 </td> <td align="right"> 2.94 </td> <td align="right"> 4.82 </td> <td align="right">  13 </td> <td align="right"> 125 </td> <td> mammary gland development </td> <td> DHODH, ESR1, ETV4, HOXA5, HOXA9, HOXD9, ID2, SERPINC1, LEF1, TBX3, TPH1, VDR, WNT2 </td> </tr>
  <tr> <td> 27 </td> <td align="center"> GO:0070374 </td> <td align="right"> 0.0013 </td> <td align="right"> 2.64 </td> <td align="right"> 6.13 </td> <td align="right">  15 </td> <td align="right"> 159 </td> <td> positive regulation of ERK1 and ERK2 cascade </td> <td> CCL26, CTGF, FGF4, FGG, NPNT, PTPN22, HTR2A, NOX4, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23, THPO </td> </tr>
  <tr> <td> 28 </td> <td align="center"> GO:0042430 </td> <td align="right"> 0.0013 </td> <td align="right"> 7.38 </td> <td align="right"> 0.85 </td> <td align="right">   5 </td> <td align="right">  22 </td> <td> indole-containing compound metabolic process </td> <td> IDO2, IDO1, AADAT, TDO2, TPH1 </td> </tr>
  <tr> <td> 29 </td> <td align="center"> GO:0044703 </td> <td align="right"> 0.0013 </td> <td align="right"> 1.65 </td> <td align="right"> 31.37 </td> <td align="right">  49 </td> <td align="right"> 813 </td> <td> multi-organism reproductive process </td> <td> ADGRG2, ZPBP, SOX30, INSL6, RPL39L, GTSF1, ZPBP2, ADAD1, ASZ1, SUN5, ADRA2C, SPINK13, CYP1A1, FAM9B, DHODH, EPOR, ESR1, KDM1B, GLI1, GNRH1, HMGB2, HOXA9, HOXA10, HOXD9, HOXD10, NANOS2, IDO1, INPP5B, SPATA31D1, NPPA, PARN, DUSP13, PCSK5, MOV10L1, RAD21L1, BOLL, FOXL2, SSTR1, BTG1, SCGB1A1, VDR, CATSPERB, SPATA16, SLC22A16, PLPP1, ADAM20, CCIN, ACVR1, FAM50A </td> </tr>
  <tr> <td> 30 </td> <td align="center"> GO:0000122 </td> <td align="right"> 0.0013 </td> <td align="right"> 1.71 </td> <td align="right"> 26.62 </td> <td align="right">  43 </td> <td align="right"> 690 </td> <td> negative regulation of transcription from RNA polymerase II promoter </td> <td> NR1H3, OSR2, HFE2, DLX4, TSC22D3, FLCN, EN1, ESR1, JAZF1, FOXC2, FOXO1, GATA1, ANKRD1, UHRF1, HIST1H1C, HHEX, HOXA7, HOXC8, HOXD8, HOXD9, ID2, ID4, LEF1, HES6, AHRR, REST, SALL1, PRDM16, SHH, SIX1, FOXL2, TBX15, TBX3, NKX2-1, SCGB1A1, VDR, LRP8, HMGA2, PCGF6, HES7, TBX18, ISX, AURKB </td> </tr>
  <tr> <td> 31 </td> <td align="center"> GO:0001501 </td> <td align="right"> 0.0013 </td> <td align="right"> 2.05 </td> <td align="right"> 12.96 </td> <td align="right">  25 </td> <td align="right"> 347 </td> <td> skeletal system development </td> <td> WFIKKN1, COL13A1, CTGF, EN1, FGF4, GJA5, HOXA10, HOXC8, HOXC10, HOXD8, HSD17B1, RHOA, MUSTN1, MATN3, HSPB11, PHEX, PAPPA2, SRD5A2, TBX3, VDR, ZFAND5, TRIM45, HMGA2, AXIN2, HES7 </td> </tr>
  <tr> <td> 32 </td> <td align="center"> GO:0006576 </td> <td align="right"> 0.0016 </td> <td align="right"> 4.63 </td> <td align="right"> 1.74 </td> <td align="right">   7 </td> <td align="right">  45 </td> <td> cellular biogenic amine metabolic process </td> <td> DBH, IDO2, IDO1, MAOA, AADAT, TDO2, TPH1 </td> </tr>
  <tr> <td> 33 </td> <td align="center"> GO:0035137 </td> <td align="right"> 0.0017 </td> <td align="right"> 5.39 </td> <td align="right"> 1.31 </td> <td align="right">   6 </td> <td align="right">  34 </td> <td> hindlimb morphogenesis </td> <td> OSR2, FGF4, HOXD9, HOXD10, SHH, TBX3 </td> </tr>
  <tr> <td> 34 </td> <td align="center"> GO:0045944 </td> <td align="right"> 0.0018 </td> <td align="right"> 1.58 </td> <td align="right"> 36.81 </td> <td align="right">  55 </td> <td align="right"> 954 </td> <td> positive regulation of transcription from RNA polymerase II promoter </td> <td> NR1H3, CEBPE, OSR2, ABRA, HFE2, DCN, JAG1, FLCN, EN1, ESR1, ETV4, EVX1, FGF4, FOXC2, FOXO1, NPNT, GATA1, ANKRD1, GLI1, UHRF1, HHEX, HMGB2, HOXA5, HOXA7, HOXA10, HOXB5, HOXC11, HOXC13, HOXD8, HOXD9, HOXD10, ID4, MNAT1, MYF5, MYF6, MYOD1, MYOG, LEF1, PGR, ZNF821, PRKD1, REST, SALL1, SHH, SIX1, FOXL2, TBX1, NKX2-1, VDR, WNT2, PAX8, HMGA2, CREB3L3, ACVR1, LHX2 </td> </tr>
  <tr> <td> 35 </td> <td align="center"> GO:0000003 </td> <td align="right"> 0.0018 </td> <td align="right"> 1.81 </td> <td align="right"> 19.24 </td> <td align="right">  33 </td> <td align="right"> 511 </td> <td> reproduction </td> <td> BASP1, ZPBP, CRIP1, ADRA2C, SPINK13, CYP17A1, DCN, DHODH, GATA1, MLH3, REC114, HOXD9, HOXD10, ID4, IDO1, NUDT1, NDP, NPPA, LEF1, PCSK5, SALL1, DMRTB1, SHH, SRD5A2, TBX3, NKX2-1, SCGB1A1, WNT2, ANTXR1, CYSTM1, MMP23B, AKR1C3, ADAM20 </td> </tr>
  <tr> <td> 36 </td> <td align="center"> GO:0035295 </td> <td align="right"> 0.0019 </td> <td align="right"> 1.83 </td> <td align="right"> 18.50 </td> <td align="right">  32 </td> <td align="right"> 484 </td> <td> tube development </td> <td> BASP1, CSNK2B, CTGF, CYP1A1, JAG1, EN1, ESR1, ETV4, FOXL1, FZD2, NPNT, MTHFD1L, GATA1, GLI1, HOXA1, HOXA5, HSD11B1, ID2, RHOA, LEF1, PCSK5, HSPB11, SALL1, RAD21L1, SFTPD, SIX1, TBX1, NKX2-1, VDR, WNT2, PAX8, LHX2 </td> </tr>
  <tr> <td> 37 </td> <td align="center"> GO:0008211 </td> <td align="right"> 0.0019 </td> <td align="right"> 6.61 </td> <td align="right"> 0.93 </td> <td align="right">   5 </td> <td align="right">  24 </td> <td> glucocorticoid metabolic process </td> <td> CYP11B1, CYP11B2, CYP17A1, HSD11B1, REST </td> </tr>
  <tr> <td> 38 </td> <td align="center"> GO:0048663 </td> <td align="right"> 0.0023 </td> <td align="right"> 3.80 </td> <td align="right"> 2.35 </td> <td align="right">   8 </td> <td align="right">  61 </td> <td> neuron fate commitment </td> <td> FOXN4, EVX1, HOXC10, HOXD10, ID2, SHH, SIX1, NKX2-1 </td> </tr>
  <tr> <td> 39 </td> <td align="center"> GO:0070098 </td> <td align="right"> 0.0023 </td> <td align="right"> 3.44 </td> <td align="right"> 2.89 </td> <td align="right">   9 </td> <td align="right">  75 </td> <td> chemokine-mediated signaling pathway </td> <td> CCL26, PPBP, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23, THPO </td> </tr>
  <tr> <td> 40 </td> <td align="center"> GO:0001503 </td> <td align="right"> 0.0024 </td> <td align="right"> 1.95 </td> <td align="right"> 13.54 </td> <td align="right">  25 </td> <td align="right"> 351 </td> <td> ossification </td> <td> OSR2, COL13A1, CTGF, JAG1, EXT1, FOXC2, CLEC5A, NPNT, GATA1, GLI1, IGSF10, ID2, ID4, RHOA, ASGR2, MYF5, MYOG, LEF1, PHEX, PRKD1, SMOC1, SHH, TPH1, AXIN2, ACVR1 </td> </tr>
  <tr> <td> 41 </td> <td align="center"> GO:0048747 </td> <td align="right"> 0.0026 </td> <td align="right"> 4.19 </td> <td align="right"> 1.89 </td> <td align="right">   7 </td> <td align="right">  49 </td> <td> muscle fiber development </td> <td> WFIKKN1, STAC3, MYF5, MYF6, MYOD1, MYOG, LEF1 </td> </tr>
  <tr> <td> 42 </td> <td align="center"> GO:0009953 </td> <td align="right"> 0.0026 </td> <td align="right"> 3.11 </td> <td align="right"> 3.51 </td> <td align="right">  10 </td> <td align="right">  91 </td> <td> dorsal/ventral pattern formation </td> <td> FOXN4, EN1, EVX1, GLI1, IFT52, SHH, NKX2-1, AXIN2, ACVR1, LHX2 </td> </tr>
  <tr> <td> 43 </td> <td align="center"> GO:0008406 </td> <td align="right"> 0.0027 </td> <td align="right"> 2.34 </td> <td align="right"> 7.29 </td> <td align="right">  16 </td> <td align="right"> 189 </td> <td> gonad development </td> <td> BASP1, INSL6, ESR1, GATA1, GNRH1, HMGB2, HOXA9, HOXA10, NUDT1, RETN, SALL1, RAD21L1, FOXL2, SRD5A2, NKX2-1, AKR1C3 </td> </tr>
  <tr> <td> 44 </td> <td align="center"> GO:0003012 </td> <td align="right"> 0.003 </td> <td align="right"> 1.89 </td> <td align="right"> 14.51 </td> <td align="right">  26 </td> <td align="right"> 376 </td> <td> muscle system process </td> <td> MYL12A, CHRND, CHRNG, CKMT2, ADRA1B, CTGF, ADRA2C, STAC3, NPNT, GJA5, HTR2A, MYH2, MYL4, MYOD1, MYOG, NEB, ATP2A1, NPPA, TRIM72, SCN1B, SLN, TBCE, TBXA2R, TNNI1, CACNG1, MYOT </td> </tr>
  <tr> <td> 45 </td> <td align="center"> GO:0048247 </td> <td align="right"> 0.0033 </td> <td align="right"> 4.00 </td> <td align="right"> 1.97 </td> <td align="right">   7 </td> <td align="right">  51 </td> <td> lymphocyte chemotaxis </td> <td> CCL26, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23 </td> </tr>
  <tr> <td> 46 </td> <td align="center"> GO:0010092 </td> <td align="right"> 0.0034 </td> <td align="right"> 5.70 </td> <td align="right"> 1.04 </td> <td align="right">   5 </td> <td align="right">  27 </td> <td> specification of animal organ identity </td> <td> HOXC11, SIX1, WNT2, PAX8, AXIN2 </td> </tr>
  <tr> <td> 47 </td> <td align="center"> GO:0007338 </td> <td align="right"> 0.0035 </td> <td align="right"> 2.80 </td> <td align="right"> 4.24 </td> <td align="right">  11 </td> <td align="right"> 110 </td> <td> single fertilization </td> <td> ZPBP, ZPBP2, SPINK13, HOXA9, HOXA10, HOXD9, HOXD10, FOXL2, CATSPERB, SLC22A16, ADAM20 </td> </tr>
  <tr> <td> 48 </td> <td align="center"> GO:0060021 </td> <td align="right"> 0.0036 </td> <td align="right"> 3.19 </td> <td align="right"> 3.09 </td> <td align="right">   9 </td> <td align="right">  80 </td> <td> palate development </td> <td> OSR2, WFIKKN1, EPHB2, FZD2, LEF1, PRDM16, SHH, TBX1, TBX3 </td> </tr>
  <tr> <td> 49 </td> <td align="center"> GO:0032501 </td> <td align="right"> 0.0036 </td> <td align="right"> 1.34 </td> <td align="right"> 108.31 </td> <td align="right"> 133 </td> <td align="right"> 3019 </td> <td> multicellular organismal process </td> <td> LRCOL1, CEBPE, MAB21L2, MYL12A, GADD45G, ADAMTS6, KRT71, CHRND, CHRNG, CCDC151, CKMT2, WFIKKN1, COL13A1, COL6A6, CRIP1, FGFBP3, CST4, OR6B3, TCF23, CYP11B1, CYP11B2, AKR1C1, AKR1C2, DHODH, DLX4, EMX2, EN1, EYA4, EVX1, EXT1, F9, F13B, FABP2, FEN1, MMRN1, FOXL1, STAC3, COL6A5, MTHFD1L, BLOC1S1, GNRH2, IGSF10, HMGB3, HOXA1, HOXA6, HOXB5, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC13, HOXD8, HOXD9, HOXD10, HSD11B1, HSD17B1, ACADL, EVX2, LCE1D, LCE3C, OR6B2, MUSTN1, STMN1, MATN3, MMP3, ASGR2, MNAT1, NUDT1, MYH2, NDP, NEB, NFE2, NMT1, NRGN, C8orf22, TRIM72, NOX4, IFT52, SERPINA10, PCSK5, CLEC1B, BPIFA1, SPTBN5, PRRX2, VCX2, HSPB11, PFKFB3, PHEX, POLR2G, CRTAC1, MCOLN3, HES6, CARMIL1, PRX, PAPPA2, ROM1, SALL1, BGN, CCL17, PRDM16, SFTPB, SFTPC, BMX, SRD5A2, TAGLN, TBCE, TBX15, LEFTY2, C4BPB, SFTPA2, UCP3, ZFAND5, KCNAB1, HDAC11, TRIM45, HIST1H3E, HIST1H3H, MAD1L1, ANTXR1, SOAT2, STON2, TMEFF1, AKR1C3, PKD2L1, KRT75, AURKB, PRDM6, LHX2, GNG8, MYOT, ENTPD1, KLK4 </td> </tr>
  <tr> <td> 50 </td> <td align="center"> GO:1901861 </td> <td align="right"> 0.0037 </td> <td align="right"> 2.77 </td> <td align="right"> 4.28 </td> <td align="right">  11 </td> <td align="right"> 111 </td> <td> regulation of muscle tissue development </td> <td> TSC22D3, FLCN, MYF5, MYF6, MYOD1, MYOG, LEF1, SHH, SIX1, TBX1, WNT2 </td> </tr>
  <tr> <td> 51 </td> <td align="center"> GO:0009605 </td> <td align="right"> 0.004 </td> <td align="right"> 1.38 </td> <td align="right"> 70.41 </td> <td align="right">  92 </td> <td align="right"> 1825 </td> <td> response to external stimulus </td> <td> NR1H3, CCL26, CEBPE, CHIT1, CRP, CNTN4, CYP1A1, DCN, DEFA5, DEFA6, DHODH, ANKRD23, ENO1, EPHB2, ESR1, ETV4, EXT1, F2, RNF152, FGF4, FGG, VEGFD, FOXO1, COTL1, FUCA2, NPNT, PTPN22, FBXL3, ANKRD1, IL17B, GNRH1, METRNL, CFH, HMGB2, HTR2A, ID2, IL12RB1, IDO1, RHOA, STMN1, FADS1, MBL2, ASGR1, NUDT1, SERPINC1, MYOD1, NFKBIB, NMT1, NPPA, NT5E, NTF3, LEF1, BPIFA1, SPTBN5, ENPP2, PPBP, PPM1B, PRKD1, RETN, EPPIN, WFDC1, BDNF, CFB, SCN1B, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23, CARD9, ABCG5, SFTPD, SHH, SLC22A3, SRD5A2, SSTR1, VAMP7, TBXA2R, NKX2-1, C4BPB, C8A, UCP3, SCGB1A1, VDR, CAMKMT, HMGA2, CREB3L3, AKR1C3, PKD2L1, LHX2, LY86 </td> </tr>
  <tr> <td> 52 </td> <td align="center"> GO:0045933 </td> <td align="right"> 0.004 </td> <td align="right"> 4.43 </td> <td align="right"> 1.54 </td> <td align="right">   6 </td> <td align="right">  40 </td> <td> positive regulation of muscle contraction </td> <td> ADRA1B, CTGF, NPNT, ATP2A1, NPPA, TBXA2R </td> </tr>
  <tr> <td> 53 </td> <td align="center"> GO:0061458 </td> <td align="right"> 0.0041 </td> <td align="right"> 1.84 </td> <td align="right"> 14.85 </td> <td align="right">  26 </td> <td align="right"> 385 </td> <td> reproductive system development </td> <td> BASP1, INSL6, CRIP1, DCN, EPOR, ESR1, GATA1, GNRH1, HMGB2, HOXA9, HOXA10, ID4, NUDT1, NDP, LEF1, RETN, SALL1, RAD21L1, SHH, FOXL2, SRD5A2, TBX3, NKX2-1, VDR, WNT2, AKR1C3 </td> </tr>
  <tr> <td> 54 </td> <td align="center"> GO:0042127 </td> <td align="right"> 0.0042 </td> <td align="right"> 1.43 </td> <td align="right"> 53.74 </td> <td align="right">  73 </td> <td align="right"> 1399 </td> <td> regulation of cell proliferation </td> <td> CCL26, MAB21L2, OSR2, CLC, DUSP15, CSNK2B, CTGF, FMC1, DBH, AKR1C2, JAG1, FLCN, ESR1, ETV4, F2, FABP6, FGF4, VEGFD, FOXO1, PRAME, PTPN22, GATA1, NOX1, GLI1, GNG5, GNRH1, HHEX, HMGB2, HOXA5, HOXC10, HTR2A, ID2, ID4, IL12RB1, IDO1, RHOA, LIFR, MNAT1, MYOD1, NTF3, NOX4, REG3A, IFT52, LEF1, PPBP, TIPIN, PRKD1, RETN, WFDC1, REST, CCL14, CCL23, TNMD, SFRP4, SFTPD, BMX, SSTR1, TBX1, TBX3, BTG1, THPO, SCGB1A1, VDR, WNT2, BIRC7, HMGA2, AXIN2, MAD1L1, PROK1, RERG, PLPP1, AKR1C3, MAGI2 </td> </tr>
  <tr> <td> 55 </td> <td align="center"> GO:0060537 </td> <td align="right"> 0.0042 </td> <td align="right"> 2.17 </td> <td align="right"> 8.31 </td> <td align="right">  17 </td> <td align="right"> 218 </td> <td> muscle tissue development </td> <td> CHRND, DCN, FOXC2, STAC3, GJA5, ANKRD1, HOXD9, HOXD10, ID2, NPPA, NOX4, FOXL2, TBX3, TNNI1, ZFAND5, KCNAB1, ACVR1 </td> </tr>
  <tr> <td> 56 </td> <td align="center"> GO:1903507 </td> <td align="right"> 0.0043 </td> <td align="right"> 1.50 </td> <td align="right"> 40.05 </td> <td align="right">  57 </td> <td align="right"> 1038 </td> <td> negative regulation of nucleic acid-templated transcription </td> <td> NR1H3, BASP1, OSR2, WTIP, HFE2, DLX4, TSC22D3, FLCN, EN1, ENO1, ESR1, HIST1H2AA, JAZF1, FOXC2, FOXO1, PRAME, HYPM, GATA1, ANKRD1, UHRF1, HIST1H1C, HHEX, HMGB2, HOXA7, HOXC6, HOXC8, HOXD8, HOXD9, ID2, ID4, MYF6, LEF1, HES6, AHRR, REST, SALL1, PRDM16, SHH, SIX1, FOXL2, TBX15, TBX3, NKX2-1, SCGB1A1, VDR, LRP8, HMGA2, HIST1H4I, HIST1H3E, HIST1H3H, PCGF6, HES7, HIST1H2AG, TBX18, ISX, AURKB, PRDM6 </td> </tr>
  <tr> <td> 57 </td> <td align="center"> GO:0046661 </td> <td align="right"> 0.0045 </td> <td align="right"> 2.45 </td> <td align="right"> 5.67 </td> <td align="right">  13 </td> <td align="right"> 147 </td> <td> male sex differentiation </td> <td> INSL6, ESR1, GATA1, HMGB2, HOXA9, HOXA10, NUDT1, RAD21L1, SHH, SRD5A2, TBX3, NKX2-1, AKR1C3 </td> </tr>
  <tr> <td> 58 </td> <td align="center"> GO:0007498 </td> <td align="right"> 0.0045 </td> <td align="right"> 2.69 </td> <td align="right"> 4.40 </td> <td align="right">  11 </td> <td align="right"> 114 </td> <td> mesoderm development </td> <td> EXT1, FOXC2, LEF1, SHH, BMX, TBX1, TBX3, HMGA2, HES7, ACVR1, LHX2 </td> </tr>
  <tr> <td> 59 </td> <td align="center"> GO:0031128 </td> <td align="right"> 0.0046 </td> <td align="right"> 5.23 </td> <td align="right"> 1.12 </td> <td align="right">   5 </td> <td align="right">  29 </td> <td> developmental induction </td> <td> HOXC11, SALL1, SIX1, NKX2-1, WNT2 </td> </tr>
  <tr> <td> 60 </td> <td align="center"> GO:0060441 </td> <td align="right"> 0.0046 </td> <td align="right"> 5.23 </td> <td align="right"> 1.12 </td> <td align="right">   5 </td> <td align="right">  29 </td> <td> epithelial tube branching involved in lung morphogenesis </td> <td> HHEX, HOXA5, SHH, NKX2-1, WNT2 </td> </tr>
  <tr> <td> 61 </td> <td align="center"> GO:0060415 </td> <td align="right"> 0.0049 </td> <td align="right"> 3.30 </td> <td align="right"> 2.66 </td> <td align="right">   8 </td> <td align="right">  69 </td> <td> muscle tissue morphogenesis </td> <td> FOXC2, FZD2, ANKRD1, MYF5, MYF6, TBX1, TNNI1, WNT2 </td> </tr>
  <tr> <td> 62 </td> <td align="center"> GO:0003007 </td> <td align="right"> 0.005 </td> <td align="right"> 2.13 </td> <td align="right"> 8.45 </td> <td align="right">  17 </td> <td align="right"> 219 </td> <td> heart morphogenesis </td> <td> FOXN4, JAG1, FOXC2, FZD2, GJA5, ANKRD1, GNG5, ID2, IFT52, SHH, SIX1, TBX1, TBX3, TNNI1, WNT2, AXIN2, ACVR1 </td> </tr>
  <tr> <td> 63 </td> <td align="center"> GO:0002548 </td> <td align="right"> 0.005 </td> <td align="right"> 3.67 </td> <td align="right"> 2.12 </td> <td align="right">   7 </td> <td align="right">  55 </td> <td> monocyte chemotaxis </td> <td> CCL26, CCL13, CCL14, CCL15, CCL17, CCL18, CCL23 </td> </tr>
  <tr> <td> 64 </td> <td align="center"> GO:0030855 </td> <td align="right"> 0.0051 </td> <td align="right"> 1.73 </td> <td align="right"> 18.19 </td> <td align="right">  30 </td> <td align="right"> 475 </td> <td> epithelial cell differentiation </td> <td> CYP1A1, AKR1C1, AKR1C2, ESR1, FZD2, GLI1, ANXA4, HHEX, HOXA5, HOXA7, HOXB5, ID2, LCE1D, LCE3C, REG3A, LEF1, MCOLN3, TNMD, SFRP4, SIX1, FOXL2, TAGLN, TBX1, TBX3, BTG1, NKX2-1, VDR, AKR1C3, KRT36, ACVR1 </td> </tr>
  <tr> <td> 65 </td> <td align="center"> GO:0048754 </td> <td align="right"> 0.0053 </td> <td align="right"> 2.64 </td> <td align="right"> 4.48 </td> <td align="right">  11 </td> <td align="right"> 117 </td> <td> branching morphogenesis of an epithelial tube </td> <td> ESR1, ETV4, FOXC2, NPNT, LEF1, SALL1, SIX1, TBX3, VDR, PAX8, ACVR1 </td> </tr>
  <tr> <td> 66 </td> <td align="center"> GO:0042060 </td> <td align="right"> 0.0053 </td> <td align="right"> 1.71 </td> <td align="right"> 19.02 </td> <td align="right">  31 </td> <td align="right"> 493 </td> <td> wound healing </td> <td> CPQ, MYL12A, ADRA2C, DCN, F2, F9, F13B, FGG, MMRN1, FOXC2, GATA1, RHOA, MUSTN1, MYF6, SERPINC1, MYH2, MYOD1, MYOG, NFE2, TRIM72, REG3A, SERPINA10, CLEC1B, CARMIL1, WFDC1, SHH, TBXA2R, C4BPB, HIST1H3E, HIST1H3H, ENTPD1 </td> </tr>
  <tr> <td> 67 </td> <td align="center"> GO:0003205 </td> <td align="right"> 0.0054 </td> <td align="right"> 2.40 </td> <td align="right"> 5.79 </td> <td align="right">  13 </td> <td align="right"> 150 </td> <td> cardiac chamber development </td> <td> ADAMTS6, JAG1, FOXC2, FZD2, GJA5, ID2, PCSK5, SALL1, TBX1, TBX3, TNNI1, WNT2, ACVR1 </td> </tr>
  <tr> <td> 68 </td> <td align="center"> GO:0035050 </td> <td align="right"> 0.0054 </td> <td align="right"> 3.25 </td> <td align="right"> 2.70 </td> <td align="right">   8 </td> <td align="right">  70 </td> <td> embryonic heart tube development </td> <td> FOXN4, FOXC2, GJA5, HHEX, IFT52, SHH, TBX3, ACVR1 </td> </tr>
  <tr> <td> 69 </td> <td align="center"> GO:0043392 </td> <td align="right"> 0.0058 </td> <td align="right"> 4.07 </td> <td align="right"> 1.66 </td> <td align="right">   6 </td> <td align="right">  43 </td> <td> negative regulation of DNA binding </td> <td> WFIKKN1, GATA1, ID2, LEF1, HMGA2, LHX2 </td> </tr>
  <tr> <td> 70 </td> <td align="center"> GO:0051781 </td> <td align="right"> 0.0059 </td> <td align="right"> 3.19 </td> <td align="right"> 2.74 </td> <td align="right">   8 </td> <td align="right">  71 </td> <td> positive regulation of cell division </td> <td> FGF4, VEGFD, RHOA, PPBP, SHH, PROK1, AURKB, KIF23 </td> </tr>
  <tr> <td> 71 </td> <td align="center"> GO:1904888 </td> <td align="right"> 0.0061 </td> <td align="right"> 3.52 </td> <td align="right"> 2.20 </td> <td align="right">   7 </td> <td align="right">  57 </td> <td> cranial skeletal system development </td> <td> FGF4, FOXC2, MTHFD1L, HOXA1, SIX1, TBX1, TBX15 </td> </tr>
  <tr> <td> 72 </td> <td align="center"> GO:0007283 </td> <td align="right"> 0.0061 </td> <td align="right"> 1.74 </td> <td align="right"> 16.86 </td> <td align="right">  28 </td> <td align="right"> 437 </td> <td> spermatogenesis </td> <td> ADGRG2, SOX30, INSL6, RPL39L, GTSF1, ZPBP2, ADAD1, ASZ1, SUN5, FAM9B, GLI1, HMGB2, HOXA9, HOXA10, NANOS2, INPP5B, SPATA31D1, DUSP13, MOV10L1, RAD21L1, BOLL, SSTR1, BTG1, CATSPERB, SPATA16, SLC22A16, CCIN, FAM50A </td> </tr>
  <tr> <td> 73 </td> <td align="center"> GO:0003156 </td> <td align="right"> 0.0062 </td> <td align="right"> 4.83 </td> <td align="right"> 1.20 </td> <td align="right">   5 </td> <td align="right">  31 </td> <td> regulation of animal organ formation </td> <td> GNG5, HOXC11, SHH, SIX1, WNT2 </td> </tr>
  <tr> <td> 74 </td> <td align="center"> GO:0021772 </td> <td align="right"> 0.0062 </td> <td align="right"> 4.83 </td> <td align="right"> 1.20 </td> <td align="right">   5 </td> <td align="right">  31 </td> <td> olfactory bulb development </td> <td> EXT1, ID2, CRTAC1, SALL1, LHX2 </td> </tr>
  <tr> <td> 75 </td> <td align="center"> GO:0001656 </td> <td align="right"> 0.0063 </td> <td align="right"> 2.90 </td> <td align="right"> 3.36 </td> <td align="right">   9 </td> <td align="right">  87 </td> <td> metanephros development </td> <td> BASP1, OSR2, FOXC2, HOXC11, ID2, SALL1, SHH, SIX1, PAX8 </td> </tr>
  <tr> <td> 76 </td> <td align="center"> GO:0003044 </td> <td align="right"> 0.0065 </td> <td align="right"> 3.97 </td> <td align="right"> 1.70 </td> <td align="right">   6 </td> <td align="right">  44 </td> <td> regulation of systemic arterial blood pressure mediated by a chemical signal </td> <td> ADRA1B, CYP11B2, GJA5, NOX1, PCSK5, OR51E2 </td> </tr>
  <tr> <td> 77 </td> <td align="center"> GO:0051146 </td> <td align="right"> 0.0067 </td> <td align="right"> 2.06 </td> <td align="right"> 8.72 </td> <td align="right">  17 </td> <td align="right"> 226 </td> <td> striated muscle cell differentiation </td> <td> CFL2, WFIKKN1, STAC3, ANKRD1, MYF5, MYF6, MYOD1, MYOG, NPPA, TRIM72, NOX4, LEF1, MYOZ1, SHH, TBX1, TBX3, ACVR1 </td> </tr>
  <tr> <td> 78 </td> <td align="center"> GO:0045639 </td> <td align="right"> 0.0069 </td> <td align="right"> 3.10 </td> <td align="right"> 2.82 </td> <td align="right">   8 </td> <td align="right">  73 </td> <td> positive regulation of myeloid cell differentiation </td> <td> JAG1, GATA1, HMGB2, HOXA5, ID2, LEF1, THPO, CD101 </td> </tr>
  <tr> <td> 79 </td> <td align="center"> GO:0014904 </td> <td align="right"> 0.0071 </td> <td align="right"> 4.65 </td> <td align="right"> 1.23 </td> <td align="right">   5 </td> <td align="right">  32 </td> <td> myotube cell development </td> <td> STAC3, MYF5, MYF6, MYOD1, MYOG </td> </tr>
  <tr> <td> 80 </td> <td align="center"> GO:2000257 </td> <td align="right"> 0.0071 </td> <td align="right"> 4.65 </td> <td align="right"> 1.23 </td> <td align="right">   5 </td> <td align="right">  32 </td> <td> regulation of protein activation cascade </td> <td> CFH, SERPINC1, CFB, C4BPB, C8A </td> </tr>
  <tr> <td> 81 </td> <td align="center"> GO:0006953 </td> <td align="right"> 0.0073 </td> <td align="right"> 3.86 </td> <td align="right"> 1.74 </td> <td align="right">   6 </td> <td align="right">  45 </td> <td> acute-phase response </td> <td> CRP, F2, ITIH4, MBL2, ORM2, REG3A </td> </tr>
  <tr> <td> 82 </td> <td align="center"> GO:0035850 </td> <td align="right"> 0.0073 </td> <td align="right"> 3.86 </td> <td align="right"> 1.74 </td> <td align="right">   6 </td> <td align="right">  45 </td> <td> epithelial cell differentiation involved in kidney development </td> <td> BASP1, JAG1, FOXC2, SALL1, PAX8, MAGI2 </td> </tr>
  <tr> <td> 83 </td> <td align="center"> GO:0035282 </td> <td align="right"> 0.0073 </td> <td align="right"> 2.83 </td> <td align="right"> 3.43 </td> <td align="right">   9 </td> <td align="right">  89 </td> <td> segmentation </td> <td> BASP1, FOXC2, HOXD8, MYF5, MYF6, LEF1, TBX3, AXIN2, HES7 </td> </tr>
  <tr> <td> 84 </td> <td align="center"> GO:0007276 </td> <td align="right"> 0.0073 </td> <td align="right"> 1.64 </td> <td align="right"> 21.07 </td> <td align="right">  33 </td> <td align="right"> 546 </td> <td> gamete generation </td> <td> ADGRG2, SOX30, INSL6, RPL39L, GTSF1, ZPBP2, ADAD1, ASZ1, SUN5, FAM9B, KDM1B, GLI1, HMGB2, HOXA9, HOXA10, NANOS2, INPP5B, SPATA31D1, PARN, DUSP13, MOV10L1, RAD21L1, BOLL, FOXL2, SSTR1, BTG1, CATSPERB, SPATA16, SLC22A16, PLPP1, CCIN, ACVR1, FAM50A </td> </tr>
  <tr> <td> 85 </td> <td align="center"> GO:0032504 </td> <td align="right"> 0.0074 </td> <td align="right"> 1.56 </td> <td align="right"> 26.78 </td> <td align="right">  40 </td> <td align="right"> 694 </td> <td> multicellular organism reproduction </td> <td> ADGRG2, SOX30, INSL6, RPL39L, GTSF1, ZPBP2, ADAD1, ASZ1, SUN5, CYP1A1, DBH, FAM9B, EPOR, ESR1, KDM1B, GLI1, GNRH1, HMGB2, HOXA9, HOXA10, NANOS2, INPP5B, SPATA31D1, PARN, DUSP13, MOV10L1, RETN, RAD21L1, BOLL, FOXL2, SSTR1, BTG1, VDR, CATSPERB, SPATA16, SLC22A16, PLPP1, CCIN, ACVR1, FAM50A </td> </tr>
  <tr> <td> 86 </td> <td align="center"> GO:0048869 </td> <td align="right"> 0.0075 </td> <td align="right"> 1.27 </td> <td align="right"> 140.52 </td> <td align="right"> 166 </td> <td align="right"> 3642 </td> <td> cellular developmental process </td> <td> NR1H3, BASP1, CAP1, CEBPE, CFL2, GADD45G, INSL6, CCDC151, OSR2, WFIKKN1, GTSF1, FOXN4, ZPBP2, WTIP, COL13A1, ADAD1, ASZ1, CRP, DACT3, CTGF, TCF23, ADRA2C, CNTN4, CYP1A1, SAXO1, AKR1C1, AKR1C2, FAM9B, JAG1, FLCN, EMX2, EN1, EPHB2, EYA4, ESR1, ETV4, EVX1, EXT1, F2, FGF4, FGG, VEGFD, FOXC2, FOXO1, PRAME, CLEC5A, STAC3, FZD2, FAM21C, NPNT, FBXO7, PTPN23, GAS1, PTPN22, GATA1, BLOC1S1, ANKRD1, GLI1, GNRH1, METRNL, IGSF10, ANXA4, HHEX, HMGB2, HMGB3, HOXA5, HOXA7, HOXA9, HOXB5, HOXB8, HOXC8, HOXC10, HOXD9, HOXD10, HTR2A, NANOS2, ID2, ID4, LCE1D, LCE3C, IL12RB1, RHOA, MUSTN1, SPATA31D1, STMN1, FADS1, MYF5, MYF6, MYOD1, MYOG, NPPA, NTF3, C8orf22, TRIM72, OMG, NOX4, REG3A, IFT52, LEF1, CLEC1B, SPTBN5, ENPP2, GPR173, MOV10L1, ULK4, CRTAC1, MCOLN3, AP1AR, HES6, CARMIL1, PRKD1, RETN, ATP10A, MYOZ1, REST, ROM1, BDNF, SALL1, SCN1B, CCL13, CCL17, PRDM16, SMOC1, TNMD, SFRP4, SHH, SIX1, BMX, BOLL, FOXL2, SRD5A2, VAMP7, TAGLN, TBX1, TBCE, TBX3, BTG1, LEFTY2, THPO, NKX2-1, TPH1, VDR, VRK2, WNT2, LRP8, PAX8, KCNAB1, CATSPERB, HDAC11, HMGA2, HIST1H4I, AXIN2, SPATA16, ANTXR1, SOAT2, SLC22A16, STON2, AKR1C3, KRT36, CCIN, ACVR1, KRT75, PRDM6, LHX2, CD101, MAGI2 </td> </tr>
  <tr> <td> 87 </td> <td align="center"> GO:0010629 </td> <td align="right"> 0.0076 </td> <td align="right"> 1.40 </td> <td align="right"> 51.58 </td> <td align="right">  69 </td> <td align="right"> 1337 </td> <td> negative regulation of gene expression </td> <td> NR1H3, BASP1, IGF2BP1, OSR2, WTIP, ASZ1, HFE2, CTGF, DLX4, TSC22D3, FLCN, EN1, ENO1, ESR1, HIST1H2AA, JAZF1, FOXC2, FOXO1, PRAME, HYPM, CNOT10, PHF19, GAS1, PTPN22, GATA1, ANKRD1, UHRF1, HIST1H1C, HHEX, HMGB2, HOXA7, HOXC8, HOXD8, HOXD9, NANOS2, ID2, ID4, MYF6, LEF1, PGR, POLR2G, BANK1, HES6, AHRR, REST, SALL1, PRDM16, SHH, SIX1, FOXL2, TBX15, TBX3, NKX2-1, C4BPB, SCGB1A1, VDR, LRP8, BIRC7, HMGA2, HIST1H4I, HIST1H3E, HIST1H3H, PCGF6, HES7, HIST1H2AG, TBX18, ISX, AURKB, PRDM6 </td> </tr>
  <tr> <td> 88 </td> <td align="center"> GO:0034754 </td> <td align="right"> 0.0076 </td> <td align="right"> 2.81 </td> <td align="right"> 3.46 </td> <td align="right">   9 </td> <td align="right">  90 </td> <td> cellular hormone metabolic process </td> <td> CYP17A1, AKR1C1, AKR1C2, ESR1, HSD17B1, SHH, SRD5A2, HSD17B6, AKR1C3 </td> </tr>
  <tr> <td> 89 </td> <td align="center"> GO:0001655 </td> <td align="right"> 0.0076 </td> <td align="right"> 1.87 </td> <td align="right"> 11.77 </td> <td align="right">  21 </td> <td align="right"> 305 </td> <td> urogenital system development </td> <td> BASP1, OSR2, CRIP1, DCN, JAG1, FLCN, EMX2, EPHB2, ESR1, FOXC2, NPNT, HOXC11, ID2, ID4, PCSK5, SALL1, SHH, SIX1, PAX8, TBX18, MAGI2 </td> </tr>
  <tr> <td> 90 </td> <td align="center"> GO:0060541 </td> <td align="right"> 0.0079 </td> <td align="right"> 2.13 </td> <td align="right"> 7.45 </td> <td align="right">  15 </td> <td align="right"> 193 </td> <td> respiratory system development </td> <td> BASP1, CTGF, GLI1, HHEX, HOXA5, HSD11B1, LEF1, HSPB11, SFTPD, SHH, SIX1, NKX2-1, WNT2, KCNAB1, GNG8 </td> </tr>
  <tr> <td> 91 </td> <td align="center"> GO:0030326 </td> <td align="right"> 0.008 </td> <td align="right"> 2.79 </td> <td align="right"> 3.48 </td> <td align="right">   9 </td> <td align="right">  91 </td> <td> embryonic limb morphogenesis </td> <td> FGF4, GJA5, HOXA10, HOXC10, HOXC11, HOXD10, IFT52, LEF1, SALL1 </td> </tr>
  <tr> <td> 92 </td> <td align="center"> GO:0050886 </td> <td align="right"> 0.0081 </td> <td align="right"> 3.00 </td> <td align="right"> 2.89 </td> <td align="right">   8 </td> <td align="right">  75 </td> <td> endocrine process </td> <td> CYP11B2, GJA5, NOX1, PCSK5, RETN, FOXL2, TBX3, OR51E2 </td> </tr>
  <tr> <td> 93 </td> <td align="center"> GO:0060840 </td> <td align="right"> 0.0081 </td> <td align="right"> 3.00 </td> <td align="right"> 2.89 </td> <td align="right">   8 </td> <td align="right">  75 </td> <td> artery development </td> <td> ADAMTS6, JAG1, FOXC2, GJA5, HOXA1, SHH, SIX1, TBX1 </td> </tr>
  <tr> <td> 94 </td> <td align="center"> GO:0045777 </td> <td align="right"> 0.0081 </td> <td align="right"> 4.48 </td> <td align="right"> 1.27 </td> <td align="right">   5 </td> <td align="right">  33 </td> <td> positive regulation of blood pressure </td> <td> ADRA1B, CYP11B2, ID2, TBXA2R, OR51E2 </td> </tr>
  <tr> <td> 95 </td> <td align="center"> GO:0010817 </td> <td align="right"> 0.0082 </td> <td align="right"> 1.70 </td> <td align="right"> 17.25 </td> <td align="right">  28 </td> <td align="right"> 447 </td> <td> regulation of hormone levels </td> <td> CPQ, SLCO1B1, ADRA2C, CYP11B1, CYP11B2, CYP17A1, AKR1C1, AKR1C2, DIO3, ESR1, FGG, MYRIP, HSD17B1, HTR2A, PCSK5, RETN, REST, SHH, SLC22A1, FOXL2, SRD5A2, VAMP7, SERPINA7, TBX3, PAX8, PDE8B, HSD17B6, AKR1C3 </td> </tr>
  <tr> <td> 96 </td> <td align="center"> GO:0050729 </td> <td align="right"> 0.0083 </td> <td align="right"> 2.60 </td> <td align="right"> 4.13 </td> <td align="right">  10 </td> <td align="right"> 107 </td> <td> positive regulation of inflammatory response </td> <td> CCL26, IL17B, IDO1, CCL13, CCL14, CCL15, CCL18, CCL23, VAMP7, CREB3L3 </td> </tr>
  <tr> <td> 97 </td> <td align="center"> GO:0007519 </td> <td align="right"> 0.0084 </td> <td align="right"> 3.29 </td> <td align="right"> 2.33 </td> <td align="right">   7 </td> <td align="right">  61 </td> <td> skeletal muscle tissue development </td> <td> CHRND, DCN, STAC3, HOXD9, HOXD10, FOXL2, KCNAB1 </td> </tr>
  <tr> <td> 98 </td> <td align="center"> GO:0051239 </td> <td align="right"> 0.0087 </td> <td align="right"> 1.30 </td> <td align="right"> 95.26 </td> <td align="right"> 117 </td> <td align="right"> 2469 </td> <td> regulation of multicellular organismal process </td> <td> NR1H3, BASP1, IGF2BP1, OSR2, CLC, FOXN4, CRP, CSNK2B, ADRA1B, DACT3, CTGF, ADRA2C, CNTN4, DBH, DCN, DIO3, JAG1, TSC22D3, FLCN, EPHB2, ESR1, ETV4, F2, FGF4, FGG, VEGFD, FOXC2, FOXO1, CLEC5A, FZD2, NPNT, FBXO7, PTPN23, PTPN22, GATA1, GJA5, NOX1, ANKRD1, IL17B, GLI1, GNG5, GNRH1, METRNL, ANXA4, HHEX, HMGB2, HOXA5, HOXA7, HOXA9, HOXB8, HOXC11, HTR2A, ID2, ID4, IL12RB1, IDO1, RHOA, MYF5, MYF6, SERPINC1, MYL4, MYOD1, MYOG, ATP2A1, NPPA, NTF3, OMG, REG3A, LEF1, ENPP2, GPR173, PPM1B, ULK4, BANK1, PRKD1, RETN, REST, BDNF, SCN1B, SMOC1, TNMD, CARD9, SFRP4, ABCG5, SFTPD, SHH, SIX1, SLN, FOXL2, VAMP7, TBX1, TBXA2R, TBX3, BTG1, THPO, NKX2-1, TNNI1, TPH1, SCGB1A1, VDR, WNT2, LRP8, PAX8, CACNG1, SYNDIG1, HMGA2, OR51E2, HIST1H4I, AXIN2, PROK1, HES7, KRT36, ACVR1, TBX18, ISX, CD101, MAGI2 </td> </tr>
  <tr> <td> 99 </td> <td align="center"> GO:0045844 </td> <td align="right"> 0.0088 </td> <td align="right"> 3.26 </td> <td align="right"> 2.35 </td> <td align="right">   7 </td> <td align="right">  61 </td> <td> positive regulation of striated muscle tissue development </td> <td> MYF5, MYF6, MYOD1, MYOG, SHH, TBX1, WNT2 </td> </tr>
  <tr> <td> 100 </td> <td align="center"> GO:0060411 </td> <td align="right"> 0.0088 </td> <td align="right"> 3.26 </td> <td align="right"> 2.35 </td> <td align="right">   7 </td> <td align="right">  61 </td> <td> cardiac septum morphogenesis </td> <td> JAG1, FZD2, GJA5, ID2, TBX1, TBX3, ACVR1 </td> </tr>
  <tr> <td> 101 </td> <td align="center"> GO:0051250 </td> <td align="right"> 0.0089 </td> <td align="right"> 2.57 </td> <td align="right"> 4.17 </td> <td align="right">  10 </td> <td align="right"> 108 </td> <td> negative regulation of lymphocyte activation </td> <td> FBXO7, PTPN22, GNRH1, ID2, IDO1, BANK1, SFTPD, SHH, SCGB1A1, MAD1L1 </td> </tr>
  <tr> <td> 102 </td> <td align="center"> GO:0042130 </td> <td align="right"> 0.009 </td> <td align="right"> 3.67 </td> <td align="right"> 1.81 </td> <td align="right">   6 </td> <td align="right">  47 </td> <td> negative regulation of T cell proliferation </td> <td> GNRH1, IDO1, SFTPD, SHH, SCGB1A1, MAD1L1 </td> </tr>
  <tr> <td> 103 </td> <td align="center"> GO:0055001 </td> <td align="right"> 0.0094 </td> <td align="right"> 2.31 </td> <td align="right"> 5.52 </td> <td align="right">  12 </td> <td align="right"> 143 </td> <td> muscle cell development </td> <td> CFL2, WFIKKN1, STAC3, ANKRD1, MYF5, MYF6, MYOD1, MYOG, NPPA, LEF1, MYOZ1, TBX3 </td> </tr>
  <tr> <td> 104 </td> <td align="center"> GO:0035914 </td> <td align="right"> 0.0096 </td> <td align="right"> 3.20 </td> <td align="right"> 2.39 </td> <td align="right">   7 </td> <td align="right">  62 </td> <td> skeletal muscle cell differentiation </td> <td> ANKRD1, MYF5, MYF6, MYOD1, MYOG, SIX1, TBX1 </td> </tr>
  <tr> <td> 105 </td> <td align="center"> GO:0050866 </td> <td align="right"> 0.0099 </td> <td align="right"> 2.29 </td> <td align="right"> 5.56 </td> <td align="right">  12 </td> <td align="right"> 144 </td> <td> negative regulation of cell activation </td> <td> NR1H3, F2, FBXO7, PTPN22, GNRH1, ID2, IDO1, BANK1, SFTPD, SHH, SCGB1A1, MAD1L1 </td> </tr>
  <tr> <td> 106 </td> <td align="center"> GO:0045596 </td> <td align="right"> 0.01 </td> <td align="right"> 1.60 </td> <td align="right"> 21.53 </td> <td align="right">  33 </td> <td align="right"> 558 </td> <td> negative regulation of cell differentiation </td> <td> NR1H3, CRP, DACT3, CNTN4, JAG1, EPHB2, F2, FOXO1, PRAME, FBXO7, GNRH1, HMGB3, HOXA5, HOXA7, HOXA9, HOXB8, ID2, ID4, RHOA, TRIM72, OMG, REG3A, GPR173, AP1AR, REST, CCL17, SHH, TBX1, TBX3, NKX2-1, HIST1H4I, AXIN2, PRDM6 </td> </tr>
   </table>
